课题基金 / 基金详情

Radiosensitization via Targeting Cell Death

Radiosensitization via Targeting Cell Death
通过靶向细胞死亡实现放射增敏
批准号:
8265034
负责人:
BO LU
金额:
$13.63万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-07-01 至 2013-05-31

项目摘要

项目成果

BO LU的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The fate of cell survival or death is a tightly regulated. Apoptosis, one of the major cell death mechanisms, is defective in many cancers. Apoptosis occurs in small fraction of cells within the irradiated solid tumors. Autophagy, a highly conserved self-elimination mechanism that utilizes lysosome/vacuoles for cellular degradation is a backup cell death pathway when apoptosis is blocked. Our preliminary data support the hypothesis that autophagy is an important alternative cell death mechanism in tumor cells exposed to ionizing radiation when the apoptotic pathway is blocked. In the absence of pro-apoptotic proteins, Bak/Bax or caspase 3/7, we found that autophagy is upregulated and occurred in over 50% of irradiated cells. As a consequence, we found that up-regulation autophagy confers increased radiation sensitivity of cancer cells. Central to this hypothesis is the concept that Bak/Bax or caspase 3/7 negatively regulate autophagy, upon radiation-induced stress and that autophagy is enhanced in cells lacking these pro-apoptotic proteins. We believe that induction of autophagy through 1) direct activation of autophagic signaling by mTOR inhibitors or overexpression of autophagic proteins; or 2) inhibition of Bak/Bax or caspase 3/7, will enhance the biological effects of radiation in cancer models. Three specific aims are proposed to test this hypothesis. Specific Aim 1 will identify mechanisms by which Bak/Bax or caspase 3/7 regulate radiation-induced autophagy. Specific Aim 2 will determine whether inhibition of Bak/Bax or caspase 3/7, induction of the autophagic pathway, and enhanced radiosensitization is a global response in cancer cells. Specific Aim 3 will determine whether induction of autophagic signaling by inhibition of mTOR or over expression of autophagic proteins enhances radiation response. The proposed study is to understand the molecular interaction between apoptosis and autophagy during radiation-induced stress and to identify novel targets for enhancing radiotherapy in cancer models. The significance of this study is to expand our understanding of the complex molecular signaling, which determines the fate of irradiated cells. This knowledge will be explored to improve the efficacy of conventional radiotherapy that is being used for cancer patients.
期刊论文(14)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1158/1078-0432.ccr-09-0589
发表时间: 2009-10-01
期刊: Clinical cancer research : an official journal of the American Association for Cancer Research
影响因子: --
作者: [Kim KW, Moretti L, Mitchell LR, Jung DK, Lu B]
通讯作者: Lu B
DOI: 10.1097/jto.0b013e31820d9d11
发表时间: 2011-04
期刊: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
影响因子: --
作者: [Sun Y, Moretti L, Giacalone NJ, Schleicher S, Speirs CK, Carbone DP, Lu B]
通讯作者: Lu B
DOI: 10.1097/jto.0b013e318226b4a6
发表时间: 2011-11
期刊: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
影响因子: --
作者: [Li W, Li B, Giacalone NJ, Torossian A, Sun Y, Niu K, Lin-Tsai O, Lu B]
通讯作者: Lu B
DOI: 10.1158/1535-7163.mct-08-0895
发表时间: 2009-06
期刊: Molecular cancer therapeutics
影响因子: 5.7
作者: [Sasi N, Hwang M, Jaboin J, Csiki I, Lu B]
通讯作者: Lu B
9
    Autoimmunity in Cardiopulmonary Toxicities from Radiotherapy and Immunotherapy
    • 批准号:
      10220911
    • 项目类别:
    • 资助金额:
      $18.7万
    • 财政年份:
      2020
    • 负责人:
      BO LU
    • 依托单位:
    Autoimmunity in Cardiopulmonary Toxicities from Radiotherapy andImmunotherapy
    Autoimmunity in Cardiopulmonary Toxicities from Radiotherapy and Immunotherapy
    • 批准号:
      10416021
    • 项目类别:
    • 资助金额:
      $67.34万
    • 财政年份:
      2020
    • 负责人:
      BO LU
    • 依托单位:
    Autoimmunity in Cardiopulmonary Toxicities from Radiotherapy and Immunotherapy
    • 批准号:
      10026508
    • 项目类别:
    • 资助金额:
      $66.16万
    • 财政年份:
      2020
    • 负责人:
      BO LU
    • 依托单位:
    国内基金
    海外基金
    面向柔性 3D 集成的仿生结构 VIA 强化方法及其机理研究
    • 批准号:
      ZCLQN26F0101
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
      黄淳
    • 依托单位:
    外电场调控二维VIA族单层的Rashba自旋劈裂和翘曲效应的理论研究
    • 批准号:
      12364017
    • 项目类别:
      地区科学基金项目
    • 资助金额:
      31.00万元
    • 批准年份:
      2023
    • 负责人:
      陈少波
    • 依托单位:
    二维层状VIA族材料的形成机制、生长及物性调控的第一性原理研究
    • 批准号:
      --
    • 项目类别:
      面上项目
    • 资助金额:
      55万元
    • 批准年份:
      2022
    • 负责人:
      朱志立
    • 依托单位:
    蓝光IIB-VIA族半导体量子点在电致发光过程中的稳定性衰退机制及其改进策略的理论研究
    • 批准号:
      --
    • 项目类别:
      面上项目
    • 资助金额:
      60万元
    • 批准年份:
      2021
    • 负责人:
      杨明理
    • 依托单位: